Hippocratic AI has reached a valuation of $1.64 billion after completing a Series B funding round, raising $141 million. This new round, which brings the company’s total funding to $278 million, was led by Kleiner Perkins, a venture capital firm known for backing tech giants such as Google, Amazon, and Genentech.
Existing investors in the company, including Andreessen Horowitz (A16z), General Catalyst, Premji, NVIDIA, SV Angel, Universal Health Services (UHS), and WellSpan Health, also participated in the round.
The success of Hippocratic AI highlights the thriving sector of AI-driven healthcare solutions, especially following the surge in artificial intelligence innovation, sparked by the release of OpenAI’s ChatGPT in 2022. The company, co-founded by CEO Munjal Shah, includes a team of physicians, healthcare professionals, and AI researchers from prestigious institutions like Johns Hopkins, Stanford, and Microsoft.
Hippocratic AI’s strong funding reflects the growing interest in AI applications for healthcare, signaling continued investment in the industry’s potential to transform medical practices and patient care.
